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Abstract
Problem: Vulvodynia, an unexplained vulvar pain, is a medical condition affecting women of all
ages, races, and ethnicities and causes pain levels ranging from very mild discomfort to extreme
suffering.
Purpose: The purpose of this study was to explore women’s knowledge toward seeking care for
vulvodynia and to explore the different types of treatments prescribed after diagnosis. The
secondary purpose of this review was to describe the treatments most effective in reducing pain
caused by vulvodynia.
Methods: A review of the literature was conducted using articles from 2001 to 2021 that focused
on diagnosis of vulvodynia and the relief of pain with various types of treatment options for
women diagnosed with vulvodynia. Multiple databases were used, and world-wide research was
compiled for context on diagnosis of vulvodynia and treatment options that worked best to
reduce pain. From the literature review, 14 articles met the inclusion criteria and were used to
compare diagnosis of vulvodynia and the different treatment methods to relieve pain.
Results: All studies suggest women did not seek immediate care or have a timely diagnosis for
vulvodynia because of speculation by health care providers that vulvodynia is a pseudoscience.
Women avoided seeking early diagnosis due to embarrassment discussing the condition and fear
of skepticism about the level of pain associated with vulvodynia. The studies showed topical
ointments and complementary treatments were the most prescribed agents. Effectiveness ranged
from no pain relief to complete relief, but the conclusions were relatively similar in all the
results. A multidisciplinary approach to vulvodynia, with mental health professionals and
gynecologic providers had the best outcomes in relieving pain and optimizing treatment.
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Conclusion: Knowledge about vulvodynia is very limited due to under diagnosis and
embarrassment of admitting that something is wrong. Most of the research conducted was a
general overview of cases and is focused on diagnosis of the condition. Benefits of therapy differ
from woman to woman and complete pain relief, or remission is elusive in many instances. CAM
therapies in combination with medications for individuals with vulvodynia to alleviate pain can
be useful and finding multiple methods that can be used together for pain relief is of value for
further research.
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Introduction
In the United States, approximately 14 million women experience unexplained vaginal
pain at some time in their lives. Approximately 16% of all women experience a condition
called Vulvodynia, unexplained vaginal pain. It is expected 30% of all women with vulvodynia
will suffer with the condition and forego seeking any medical treatment or intervention. Medical
attention is frequently not pursued for women with symptoms of vulvodynia due to lack of
knowledge or embarrassment about the condition, resulting in unnecessary chronic, discomfort
and suffering. Several types of treatments and therapy are available for women with vulvodynia
and the phenomena needs requires directed discussion and non-judgmental care between a
woman and her provider. Vulvodynia is a multifactorial condition with subjective symptoms
varying greatly between women and viable treatment options can be tailored to provide relief for
each woman (Vulvodynia/Vestibulodynia, 2020).
Available treatment options are not precise, and guidelines differ, since a large
percentage of women with vulvodynia do not seek treatment until the condition is advanced.
Variance in clinical manifestations from woman to woman is subjective. Variability in clinical
manifestations and level of discomfort to discuss the issue with a provider by women who aren’t
expressing their pain can be inhibitory to traditional research methods about the condition.
Prescriptive drug therapy and complementary and alternative medicine (CAM) can be used
individually or in combination for the treatment of vulvodynia, but an increased willingness to
discuss vaginal problems often prevents their use. Methods to encourage women to discuss
vaginal pain and early diagnosis of vulvodynia can lead to early treatment and relief. Although
the underlying mechanism related to vulvodynia is poorly understood, further research into
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women’s understanding of the condition and options for therapy is of value to addressing the
condition.
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Problem statement
The diagnosis of vulvodynia and quantifying universal treatments for women suffering
from the condition is difficult identify in a population. Although pharmacologic therapies such as
topical hormones and anesthetics are the first line of treatment and therapy for vulvodynia,
alternative and complementary therapies, as adjuvant therapy with prescribed agents, can be
implemented when developing a treatment plan to alleviate pain and increase QOL in women
with vulvodynia. Complementary therapies, such as biofeedback, pelvic floor, and
transcutaneous electrical nerve stimulation (TENS) along with home remedies such as loosefitting clothing, non-scented products and urination after sexual activity are effective when used
together. The use of CAM therapies in conjunction with prescriptive pharmacologic agents for
vulvodynia can be evaluated as effective combinations to alleviate pain.
The effects of CAM, as well as the combination of pharmacologic therapies with CAM,
in women with vulvodynia have diverse outcomes for the relief of pain in women with
vulvodynia. Research suggests several alternative therapies can have a positive impact on pain in
women with vulvodynia, leading to an overall increase of the QOL in women with the condition.
However, the research is vague and does not give a specific combination of therapies that are
beneficial when used together. Further research is needed to understand vulvodynia and if there
are specific treatments in CAM and pharmacologic treatments best relieving pain when used
together, as well as the benefits each treatment can provide for the different types of vulvodynia.
Evidence suggests a combination of therapies are the most effective for treating the pain
associated with vulvodynia and increasing the quality of life for women. There are many
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unanswered questions concerning vulvodynia along with the CAM and pharmacologic
treatments that work best together.
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Purpose
The purpose of the literature review was to explain women’s vulvodynia and explore the
CAM and pharmacologic treatment methods used to treat the pain associated with the condition.
Evidence describing improvement in pain and overall QOL related to combination treatments
used to treat vulvodynia is sparse. Additionally, knowledge about vulvodynia is very limited due
to under diagnosis and embarrassment of admitting something is wrong within the pelvic region
of the body. Individualized therapy for vulvodynia and women’s benefits from differing
treatments that relieve the pain of vulvodynia makes it difficult to offer specific cures. CAM
therapies in combination with medications to alleviate pain for individuals with vulvodynia can
be useful in finding tailored and individualized therapy to give women the highest possible QOL.
The secondary purpose of this literature review was to explore women’s knowledge about
seeking care for vulvodynia and discuss reasons women avoid seeking care for the condition.

5

Background
Unexplained vaginal pain, also termed vulvodynia, is described subjectively by women
as affecting the vulva, lasting longer than 3 months, and has no specific origin or triggering
factor. (Sorg, 2001) The vulva is part of the external section of the vaginal and includes the
vestibule, the labia minora majora and the clitoris. (American Cancer Society,2021) There are
several different types of vulvodynia described in the literature. Generalized vulvodynia occurs
in different areas of the vulva and may occur in increments. Localized vulvodynia is limited to
one area of the vulva and is usually characterized by a burning sensation resulting from touch or
pressure in the area and surrounding tissues. Most forms of vulvodynia are idiopathic and have a
multifactorial origin. Vulvodynia can be influenced by infection, hyper-stimulated nerve
endings, stretching or irritation of uterosacral ligaments (USL) or by some other unknown
mechanism. Identifying vulvodynia with a specific etiology can be elusive. The etiology and
pathophysiology of vulvodynia is variable and a scant amount of research linking the causative
factors for vulvodynia has been difficult to specify. Vulvodynia is a subjective, painful sensation
differing from woman to woman and has a complex underlying etiology that is poorly
understood by health care providers.
Although the condition is experienced by a large subset of women and is often
debilitating, it can go undiagnosed for years. Women with the condition have daily vaginal pain
and discomfort but do not recognize the symptoms and consider the pain as a normal
phenomenon, causing the condition to be under diagnosed and treated. Women recognizing the
pain in the vaginal canal is abnormal are often too embarrassed to talk about it with anyone,
including friends, family members or health care providers, leading to further discomfort and
embarrassment. Lack of recognition and discomfort discussing chronic vaginal pain are the
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primary reasons vulvodynia is left untreated and are due to a combination of lack of knowledge
and understanding about vulvodynia and the stigma that women should not discuss pain
associated with the reproductive organs. Even when women diagnosed with vulvodynia become
discouraged after the diagnosis is made because the process leading to diagnosis can be tainted
by disbelief or lack of a diagnostic test to confirm the condition. The word “vulvodynia’ can
cause woman discomfort and anxiety. It is estimated, 65% of women are uncomfortable using
the words vagina or vulva and 45% of women are uncomfortable talking about vaginal problems
in any setting, including with a health care provider. Women expect to live with the pain and
accept it as a normal part of life.
Vulvodynia is a treatable condition and is associated with a chronic diagnosis. A
combination of pharmacological and complementary and alternative (CAM) therapies has the
greatest effect on decreasing pain associated with vulvodynia. There is no standard therapy for
all women with vulvodynia. Every woman has a different experience, and several different
combinations of therapy can be tested before one is found to be effective. The combination of
therapy has the anticipated effect of alleviating pain or pressure in vaginal tissues and increasing
quality of life in women with vulvodynia. several common treatments having the greatest effect
in alleviating the pain associated with vulvodynia include:
Home remedies:
− Unscented detergents
− 100% cotton underwear
− Loose fitting clothing
Pharmacological remedies:
− Topical estrogens
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− Topical anesthetics (lidocaine)
− Antihistamines
Alternative therapies:
− Biofeedback
− Transcutaneous electrical nerve stimulation (TENS)
− Physical therapy
Once an effective treatment method is established, women can live a relatively
comfortable life without pain. Since vulvodynia is not a one size fits all diagnosis and treatments
are multifactoral, combination therapy from all three categories seems to work the best. A
mixture of a topical estrogen with a topical anesthetic along with loose fitting clothes and
unscented fragrances seems to have the best outcomes. In some instances of provoked
vulvodynia where a specific cause can be identified, surgical extraction of the vestibules is
effective. There is no specific treatment for all cases of vulvodynia no matter which category of
the condition a woman experiences on a daily basis. All women have different experiences with
vulvodynia and what works for one does not necessarily work for all.
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Method
A comprehensive review of the literature was performed using research articles
available from 2001 to 2022 regarding the types of treatments for vulvodynia and which
treatments best relieved pain and increased QOL in women. The focus was related to the
different treatment types used alone and in combination with other agents for vulvodynia.
Databases used to search for articles included EBSCO host databases, Medical Literature OnLine (Medline), Cumulative Index to Nursing and Allied Health Literature (CINAHL), and
JSTOR databases. Searches will use a combination of the following terms: Vulvodynia*,
unexplained vaginal pain*, alternative*, complementary*, pharmacologic*, benefit*, therapies*,
and treatments*. Inclusion criteria will consist of 1) published research in English, 2)
complementary and alternative therapies in combination with prescriptive agents, and 3) the
various types of vulvodynia and which combination of treatments works best with each. Articles
excluded focused on individual therapies for vulvodynia outside of the main stream of standard
practice and combination therapies with no significant effect on the QOL of the women.
The data was compiled into a table that synthesized the relationship between the benefits
of CAM in combination with pharmacologic treatments in alleviating pain and improving QOL
in women with vulvodynia. Additional information on the benefits of AM in combination with
pharmacologic treatments will be tabled based on the information obtained. Data will show the
evidence for the use of CAM and pharmacologic treatments in combination for the treatment of
individuals suffering from vulvodynia was explored (Appendix A).
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Results
A review of eleven articles was conducted utilizing inclusive criteria to determine which
treatments for vulvodynia were the most effective. Of these eleven, only four were from the United
States. The methods of study consisted mostly of questionnaires and experimental trials. None of the
articles yielded a definitive treatment option which corresponds with the idea that women are afraid to
even seem treatment for this condition based on the ideology behind it. By many, it is viewed as a
pseudoscience since for most women, there is no specific cause. Because of this speculation, women
avoid seeking treatment all together or prolong a diagnosis. However, of the options available, a
multidisciplinary approach with mental health providers and gynecologic intervention had the best
outcomes in relieving pain and optimizing treatment. Four articles suggested that a multidisciplinary
approach to treating pain associated with vulvodynia was the most effective. Therapeutic interventions
for vulvodynia included pelvic floor training, topical/oral drug therapy (lidocaine, steroids, antiinflammatories), lifestyle modifications, and cognitive behavioral therapy (CBT).

Pharmacologic Intervention
Drug therapy was one of the main therapeutic interventions examined when determining
effective treatment options for vulvodynia. Several of the pharmacologic options available to reduce
pain associated with vulvodynia included lidocaine, antihistamines, steroids, and antifungals. The type
of drug therapy prescribed depended on the provider along with the symptoms and onset, but the
majority of agents were orally and topically administered. The function of the agents prescribed for
vulvodynia was to reduce pain and alleviate symptoms associated with the condition. Antihistamines
were used to alleviate itching and to help women get more rest. Lidocaine or other local topical
anesthetics was used for sexual relief and was recommended to be applied “30 minutes before sexual
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intercourse to reduce your discomfort.” (Advocare,2021) Steroids were used to reduce the immune
response in hopes of reduce inflammation. And finally, anti- fungal/ antibiotics were used if the
anticipated origin was an infection.
In the study conducted by Rey Novoa (2021), a local anesthetic, procaine, was injected into the
study participants and pain was evaluated before and after the injection. Results suggested the placebo
group had no significant pain reduction while the group that received the injection noted a pain
reduction from greater to seventy percent to less than thirty percent in three of the participants while the
other two experienced complete relief. The relief seemed to last until the follow up appointments and as
long as six months from the initial injection. Several of the participants still experiencing pain relief past
the expected date. This was the only study to provide statistical analysis in correlation with
effectiveness of the intervention.
In another study, 367 participants were contacted regarding a topical medication they were given
for pain relief related to vulvodynia. The medication was “amitriptyline 0.5% plus oestriol 0.03% in
organogel” (Ruoss,2021) which is used to treat neuropathic pain. All age groups saw a relief in pain in
at least 50% of the participants with the age group of 30-50 seeing the greatest pain relief. The number
of participants in each age group was not determined but the medication is seen to be effective in
majority of women regardless of age. According to the experiment, “topical AOO is an effective and
well-tolerated treatment for vulvar pain” (Ruoss,2021) and more research into this medication could
prove to be very effective in treating pain associated with vulvodynia.

Complementary and alternative interventions
Another type of intervention used for pain relief in vulvodynia CAM. CAM includes
pelvic floor therapy, transcutaneous electrical nerve stimulation (TENS), and lifestyle
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modifications such as wearing loose fitting clothing, avoiding baths, wearing 100% cotton
underpinnings, and avoiding scented products in the pelvic region. CAM interventions were
used in combination with drug therapy in all the articles reviewed and synthesized for the
treatment of pain in vulvodynia. No single study discussed CAM therapy alone as a therapeutic
intervention for vulvodynia. The studies including CAM did not evaluate CAM as an
independent variable from prescriptive agents and discussed pharmacological therapy in
conjunction with CAM as a single quantifiable variable. Therefore, traditional interventions
alone may not be enough to relieve the pain caused by vulvodynia.

Experimental Procedures
There were also a experimental procedures used as a therapeutic intervention for
vulvodynia. This included the study by Schonfeld and the mechanical support of uterosacral
ligaments (USL) and the study by Hurt that explored extracorporeal shock wave therapy in pain
relief caused by vulvodynia.
In the study by Schonfeld, participants diagnosed with provoked vulvodynia were tested
for an improvement in their condition when support was added to the uterosacral ligaments. For
the trial group, a wide swab that was sufficiently broad was added to mechanically support the
USL. The support was expected to relieve the pressure of the pelvic structures off the nerve
plexuses thought to be causing the muscular dysfunction associated with provoked vulvodynia.
However, the overall pain reduction seen with the trial manipulation was only 18.4% making the
overall effectiveness of treatment not successful.
Another experimental procedure conducted in women with vulvodynia of an idiopathic
origin focused on the use of extracorporeal shock wave therapy (ESWT). The “device used was a
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standard electromagnetic shock wave unit with a focused shock wave handpiece” (Hurt,2020) to
deliver shock to the perineal area weekly. Of the 31 women receiving the treatment, all recorded
a pain reduction of greater than 30% that stayed constant and the follow ups at one, four, and six
weeks. The other 31 participants the received the placebo recorded no significant pain reduction
from baseline. This experiment if conducted with a larger sample group in different places
around the country could prove to be an effective therapeutic intervention in the treatment of
vulvodynia.

Multidisciplinary Approach
All of the articles reviewed and synthesized to answer the research questions focused on
the use of multiple therapies to treat vulvodynia to optimize pain relief. The use of drug therapy
along with CAM was found to have the greatest effect on alleviating pain associated with
vulvodynia.
In the study by Mitchell, Australia women on average reported feeling the most relief
when seeing a combination of specialist, utilizing pelvic floor training, taking topic/oral
medication, and having an overall idea of what encompasses vulvodynia. The specialist included
a general practitioner, medical specialist, and physiotherapist. The medications used were not
specific for the treatment of vulvodynia but proved to be effective when used in combination
with the other interventions. Another study by Goldstein focused on the same exact interventions
but went into even less detail regarding specifics. Both articles expressed multiple interventions
used in combination were necessary to get optimal pain relief however no scientific basis for
pain relief was offered.
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Discussion
The studies examined in this literature review offer positive insight into CAM
combined with prescriptive drug therapy for the pain associated with vulvodynia. The synthesis
for the study also provided insights into the reasons why women do not seek treatment for
vulvodynia or receive delayed diagnosis for the condition. Research findings showed the benefits
of using a multidisciplinary approach as therapeutic interventions for vulvodynia, however,
results were often surface. Although many of the studies did not review definitive results for
treatment for vulvodynia, using combination therapy to treat the pain associated with vulvodynia
was the most effective form of treatment.
Studies regarding the effectiveness of therapeutic interventions regarding pain associated
with vulvodynia were limited. Pharmacologic treatments were often the first line of treatment
followed by lifestyle modifications and counseling but overall, the most pain relief was seen
when a multidisciplinary and multi-faceted therapeutic approach was used. Most of the studies
conducted for vulvodynia were a general overview of cases and focused on diagnosis of the
condition and options for treatments but did not go into the effectiveness of pain alleviation.
In the study by Schonfeld which focused on supporting the uterosacral ligaments to
alleviate some of the pain associated with provoked vulvodynia, an overall decrease in pain out
of the seventeen subjects tested was only 18.4%. With a wider test subject base, this treatment
could prove to be effective in pain alleviation over time, but this only includes the female
population with provoked vulvodynia. This means that for this form of vulvodynia, there is a
causative factor that is believed to be influencing the pain. And since for most women who
experience vulvodynia, it is idiopathic in nature, this treatment is not much of a benefit.
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The other studies focused more on the use of combination therapy to alleviate pain.
Overall, benefits of therapy differ from woman to woman and complete pain relief, or remission
is elusive in many instances. Vulvodynia is not a one size fits all diagnosis and can often types
go undetected due to fear and embarrassment or overall lack of recognition.
This literature reviews provides different types of therapeutic interventions that are used
for women who experience vulvodynia. The effectiveness of each intervention depended on the
person and their baseline pain level. Treatments that provided complete relief to some provided
very little to others. Most of the studies revealed that a multidisciplinary approach was most
effective. The studies that did not discuss this relied on pharmacologic interventions, mostly a
local anesthetic. The sample sizes in all studies were relatively small so for future experiments, it
may prove beneficial to have a greater number of subjects to test true effectiveness among the
female population. Studies that discussed why women are embarrassed to speak about
vulvodynia and the female reproductive system in general were also limited. The lack of research
about why women do not speak up and seek treatment could also be a factor that contributes to
the lack of knowledge of beneficial therapeutic intervention.
In conclusion, obtaining definitive answers for effective therapeutic interventions for
vulvodynia is still a way off. Most of the research conducted for vulvodynia was a general
overview of cases and focused on possible treatments for the condition rather than overall
effectiveness. Complementary and Alternative Medicine (CAM) therapies, in combination with
drug therapy, to alleviate pain can be useful and multiple methods can be combined for
optimizing pain relief. Experimental interventions along with surgical ones were also discussed
although not as popular as a multidisciplinary approach. The benefits of therapy differ from
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woman to woman and complete pain relief, or remission is elusive in many instances. More
research is critical for continued development of interventions that could help alleviate the pain
suffered by all women diagnosed with vulvodynia.
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Limitations
This literature review had several limitations. Although the articles did discuss
therapeutic interventions for vulvodynia, most of them did not discuss overall effectiveness. The
length of effectiveness as also left out of almost all studies and the length of treatment was also
not mentioned. The pieces of missing information show a gap in the literature and are important
in determining if a standardized intervention for alleviating the pain of vulvodynia would be
beneficial rather than trial and error therapeutic approaches. Most studies used smaller sample
sizes with inconclusive data so overall effectiveness could not be determined.
In the study by Mitchell (2021) along with Goldstein (2016), the types of therapeutic
interventions recommended are discussed but how effective they were was left out. Both studies
again claim that a multidisciplinary approach is the most beneficial, but they do not have hard
statistics to back it with. Both studies agree the first line of pain intervention in vulvodynia is a
combination of drug therapy, pelvic floor therapy and CAM interventions. However, neither
study goes over the amount of pain relief experienced or the length of the therapies. The types of
medications complementary and alternative therapies recommended was also left out. There was
also no exact sample size for the Goldstein article stating that it was based on the general
population of women experiencing vulvodynia while the sample size by Mitchell (2021) was
only 50 women from Australia.
Another limitation is the paucity of research articles examining why women avoid
seeking care for vulvodynia. However, the study by Tornava (2018) discusses resident medical
students lacked knowledge on diagnosing vulvodynia and how to treat it, showing awareness of
the condition is not universal. Lack of awareness and recognizing vulvodynia as a painful health
condition can contribute to avoidance behaviors in women seeking treatment seeking treatment
17

for the condition and feeling they are not being taken seriously. Avoidance also contributes to the
perception vulvodynia is a pseudoscience because healthcare providers do not understand or
recognize vulvodynia exists. There is a stigma about discussing the female reproductive system
with providers and a lack of knowledge about the condition in the healthcare research, causing
women to be easily discouraged to seek care for the pain associated with vulvodynia.
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Implications for Nursing
Vulvodynia is a subjective phenomenon with an unknown etiology and has
therapeutic interventions to relieve pain and discomfort in women when health care professionals
are conversant about the condition. Healthcare providers can identify early signs of vulvodynia
and ask questions that could help make an early diagnosis without discouraging women from
seeking necessary treatment. Participating in open discussions with healthcare providers about
vulvodynia and isolated perineal pain, including the surrounding muscular tissue and fascia
structures can help women feel comfortable speaking about how they feel and getting the
necessary relief for their symptoms. To get optimal care transparency, communication, and
education between both the patient and the healthcare provider needs to remain top priority when
addressing women’s health issues. Continued research with greater sample sizes would be
beneficial to determine the cause of vulvodynia and to identify common therapeutic interventions
providing best relief for the condition.
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Table of evidence
Appendix A

Author(s)
Year
Location

Study Design
& dates

Sample Size &
Screening Measures

Results

Was the research question answered?

Schonfeld
(2021) Israel
and Australia

prospective,
single-blind,
randomized,
controlled pilot
trial using a
within-participant
cross-over design.

N-17

No significant decrease in pain was
detected with the sham trial
compared to the trial manipulation
with order of manipulation having
no effect on outcome.

Somewhat. This article shows a potential
treatment for provoked vulvodynia which is
only a subsection for the overall question.

2017-2018

Approved by institutional
review board of the
Galilee Medical Center of
the Israeli Health Ministry
Women between the age
of 18-35 with moderate to
severe PV.
Excluded: Diagnosis of
generalized vulvodynia,
vulvar pain with a specific
cause and previous
surgical treatment.

Mitchell (2021)
Australia

A cross-sectional
online survey
May-August
2019

N- 50
Criteria included a
diagnosis of vulvodynia,
currently residing in

More experiments are needed with longer
sample sizes to see true effects.
Average decrease in pain of all
subjects 18.4%
Median decrease in pain of all
subjects 12.5%

Participants were recorded seeing
on average 3 different types of
specialists to manage their
vulvodynia symptoms.
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Yes, this helps to answer my question by more
information is needed.
This article does not specify which type of
vulvodynia is being looked at and suggests that

Australia and over the age
of 18.

Goldstein
(2016)
Washington,
DC, Canada,
New York, and
Pennsylvania

Committee
review of the
scientific
evidence on the
assessment
and treatment of
women's genital
pain.

General population of
women experiencing
sexual pain.

Ruoss (2021)
Australia

Contacted via
verified email to
report pain levels
and changes

N-1174 women
1054 who agreed to
participate in follow ups

May 2017-Feb
2020
Lua (2017)
Nevada

Truven
MarketScan
Commercial
Claims and
Encounters
databases

N- 12,584
Women over the age of 18
with a diagnosis of
vulvodynia enrolled for at
least a year from date of
diagnosis

2009-2013
Schlaeger
(2017)
Illinois, China,
and Florida

Exploratory study

N- 36 women
A diagnosis of vulvodynia
along with a TCM

The most common treatment
options recommended for these
patients was pelvic floor training
exercises, oral and topical
medications, and general
information.
A multidisciplinary approach is
recommended for treatment of
vulvodynia. Among these
treatments, psychological
interventions, pelvic floor therapy
and medications are among first
line agents.

the recommended treatments have very little
evidence to back up effectiveness.

Out of the 1054 participants that
agreed to be contacted, only 376
responded.

Yes, this article discusses a topical treatment
for vulvodynia and the effectiveness for all age
groups is significant however it does not
discuss the exact sample size and it does not
specify which form of vulvodynia it is being
tested for.

The greatest response was from
participants who were in the 30–
50-year age category with a 66.7%
effective rating.
Out of the 24,122 women who had
a diagnosis of vulvodynia, only
12,584 qualified for the study.

Yes, this article helped to confirm that fact that
a multidisciplinary approach is the most
effective along with reiterating fact that there is
little research on the most effective treatments
for vulvodynia.

No, this article only discusses the most
common medications that women were
prescribed for vulvodynia but not how effective
each was.

Showing that the most common
prescriptions for vulvodynia were
antidepressants, opiates,
antifungals and lastly steroids.
Each person was given a group in
the traditional Chinese medicine
(TCM) category. The groups were
divided into extreme cold and
extreme heat. The group with
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No, this article does not help to answer my
although it does discuss different types of
TCM, it does not provide any to date insight on
how to treat vulvodynia. It only offers
information that could maybe be used at a later

Rosen (2021)
Canada

Randomized
controlled trial
2021

Tornava (2018)
Finland

Cross selection
Web based
survey

Rey Novoa
(2021) Spain

Case series
experiment

assessment and
completion of SF-MPQ

extreme heat seemed to sense pain
at a higher intensity (4.1 compared
to 3.3)
Higher mean score for neuropathic
sensory descriptors in the excess
heat pattern group while higher
nociceptive sensory descriptors
were detected in the extreme cold
group signifying that there are
different ways that pain is
perceived and could eventually
lead to a larger discovery in terms
of effective vulvodynia treatments

date once more research had been conducted on
the topic.

N-108 couples

Researchers found that cognitive
behavior couples therapy (CBCT)
saw better result in improving
women’s sexual function post
treatment when the relationship
was high anxiety, lower sexual
goals whereas lidocaine saw better
results when the sexual goals of the
relationship were also high.
Student healthcare staff was shown
to have irregular awareness of
vulvodynia.
They lacked knowing how to treat
it and knowledge on what it was.
They decently understood how to
support patients diagnosed.

Yes, it shows that when the sexual desire is
high in a relationship where a woman has
vulvodynia, lidocaine is an effective treatment.
However, the research suggests that it may
need to be done in combination with CBCT.

0.5% procaine which is a local
anesthetic was injected into 5
participants. 2 revealed complete
relief while the other 3 had
significant. Pain was reduced from
70% to about 30% after
intervention and maintained over
time.

Yes, this article shows the effectiveness of one
type of pharmacologic treatment that had
already been introduced in previous studies.
However, the sample size too small to
determine overall effectiveness for most
women suffering from pain associated with
vulvodynia.

Unknown number of
women with a diagnosis
of provoked vulvodynia.
Researchers used
pretreatment
demographics (age, sex,
relationship length)
Student healthcare
professionals over the age
of 18
13 different student
healthcare units
N-191
5 women, ages 33-44
years, with LVP (localized
vulvar pain)
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Since the sample size was so small, further
research is needed.
This article supports my claim that there is not
enough knowledge surrounding vulvodynia
along with its treatment options. It also shows
that across the board in different medical units,
healthcare providers are not properly
diagnosing and do not know what vulvodynia
is.

Hurt (2020)
Prague

Munday (2007)
USA

A prospective,
randomized,
double-blind,
placebocontrolled study
was conducted
between 2015 and
2018 following a
feasibility study.

62 women with
vulvodynia for at least 3
months

Retrospective,
qualitative, indepth interview
study

29 women diagnosed with
vulvodynia

31 placebo participants
31 treatment participants

In the test group, a significant
decrease in pain over 30% was
seen at all follow up apt using
extracorporeal shock wave therapy
(ESWT). (1,4 and 12 weeks.)
Reductions in VAS (P<0.01) and
CST (P<0.01) were also observed.

This article showed a way to attempt to treat
idiopathic vulvodynia. The results were
promising but the experiment needs to be
conducted in other countries with larger sample
sizes.

A multidisciplinary approach was
implemented involving medical
evaluation and treatment,
psychotherapy, physiotherapy and
dietary advice of 29 women. 27 of
the 29 a significant benefit in pain
reduction while 9 who had
completely completed the program
were pain free.

Kind of. This article talks about the benefits of
a multidisciplinary approach for this group of
women but does not go into specifics of which
type in each category was most beneficial.
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Figure 1
Appendix B

Potentially relevant articles identified after screening
databases
(Medline, CINAHL, and JSTOR)

(n=200)

Studies retrieved for a
more detailed review
(n=26)

Studies excluded due to
not meeting inclusion
criteria
(n=174)

Studies excluded after more
detailed review due to not
meeting inclusion criteria
(n=15)

Studies included that met inclusion criteria
(n=11)
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